Compare NOCIL with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -5.23% of over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
With ROE of 3.6, it has a Very Expensive valuation with a 1.5 Price to Book Value
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 2,774 Cr (Small Cap)
43.00
37
1.23%
-0.16
3.56%
1.53
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Jul-30-2025
Risk Adjusted Returns v/s 
Returns Beta
News

NOCIL Ltd Surges 7.16% to Day's High of Rs 178.6 — Outperforms Sector by 6.55 Percentage Points
The Sensex slipped 1.05% on 24 Mar 2026, yet NOCIL Ltd surged 7.16%, outperforming its Specialty Chemicals sector by 6.55 percentage points. This sharp single-session gain, reaching an intraday high of Rs 178.6, stands out as a stock-specific event amid a broadly weak market environment.
Read full news article
NOCIL Ltd Surges on Heavy Value Trading Amid Strong Institutional Interest
NOCIL Ltd, a specialty chemicals company classified as a small-cap with a market capitalisation of ₹2,671 crores, witnessed a remarkable surge in trading activity on 24 March 2026. The stock outperformed its sector and the broader market, registering an 11.13% gain in a single day amid heavy volumes and heightened investor interest, despite a recent downgrade to a Strong Sell rating by MarketsMOJO.
Read full news article
NOCIL Ltd Surges on Exceptional Volume Amid Strong Buy Signals
NOCIL Ltd, a specialty chemicals company, witnessed extraordinary trading volumes on 24 Mar 2026, with shares surging over 9% intraday and outperforming its sector significantly. This surge comes amid a strong three-day rally, signalling heightened investor interest despite a recent downgrade to a Strong Sell rating.
Read full news article Announcements 
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
17-Mar-2026 | Source : BSEDisclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulation2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
16-Mar-2026 | Source : BSEDisclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements )Regulations 2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
07-Mar-2026 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 06 2026 for Hrishikesh Arvind Mafatlal as a Trustee of (Gurukripa Trust)
Corporate Actions 
No Upcoming Board Meetings
NOCIL Ltd has declared 20% dividend, ex-date: 30 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
18.6633
Held by 9 Schemes (5.68%)
Held by 60 FIIs (4.47%)
Hrishikesh Arvind Mafatlal(as A Trustee Of Gurukripa Trust) (18.16%)
Icici Prudential Retirement Fund-pure Equity Plan (3.56%)
45.19%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -1.47% vs -4.66% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -23.68% vs -29.78% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -10.63% vs -1.70% in Sep 2024
Growth in half year ended Sep 2025 is -57.54% vs 12.58% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.63% vs -3.23% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -52.94% vs -10.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -3.60% vs -10.63% in Mar 2024
YoY Growth in year ended Mar 2025 is -22.66% vs -10.83% in Mar 2024






